Human CD20 Monoclonal Antibody

Catalog Number: ABB-YR0130
Article Name: Human CD20 Monoclonal Antibody
Biozol Catalog Number: ABB-YR0130
Supplier Catalog Number: YR0130
Alternative Catalog Number: ABB-YR0130-1MG,ABB-YR0130-20MG,ABB-YR0130-5MG
Manufacturer: ABclonal
Category: Antikörper
Application: ELISA, NeA
Immunogen: Human CD20
Alternative Names: B1, S7, Bp35, CD20, FMC7, CVID5, LEU-16, MS4A1
Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil.In contrast to rituximab, which is a classic type I CD20 antibody, obinutuzumab binds to type II CD20 antibodies. This allows obinutuzumab to have a much higher induction of antibody-dependant cytotoxicity and a higher direct cytotoxic effect than the classic CD20 antibodies.
NCBI: 931
UniProt: P11836
Purity: >95% Determined by SDS-PAGE
Target: CD20
Application Dilute: In Vivo Grade Recombinant Human IgG1 Kappa Isotype Control Antibody
Application Notes: Cross-Reactivity: <1EU/mg (<0.001EU/µg)Determined by LAL gel clotting assay. ResearchArea: Cancer immunology